Profit

Glenmark Pharma's wait for licencing deal ends

PUBLISHED ON: May 3, 2010 | Duration: 2 min, 39 sec

  
loading..
The year-long wait for Glenmark Pharmaceuticals to cut a licencing deal is finally over. The company partners with Sanofi-Aventis to develop and commercialise Glenmark's novel molecules for pain treatment led by GRC 15300
ALSO WATCH
The Biggest Stories Of September 23, 2021

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com